For over 50 years, Bloomberg Tax’s renowned flagship daily news service, Daily Tax Report® has helped leading practitioners and policymakers stay on the cutting edge of taxation and...
By Erin McManus
The U.S. Supreme Court declined to hear Dow Chemical Co.'s appeal of a lower court’s rejection of its creative attempt to monetize depreciated patents while claiming substantial tax deductions ( Chemtech Royalty Assocs., LP v. United States, U.S., No. 16-347, cert. denied 1/9/17 ).
Dow challenged both the tax bill and penalty for its asset-backed financing arrangement through which it contributed patents to partnerships and claimed $2 billion in deductions for royalty payments and depreciation through the partnerships while allocating only a small fraction of the income of the partnerships. The U.S. Court of Appeals for the Fifth Circuit ruled that the foreign banks Dow claimed were partners really weren’t, and the partnerships were shams.
The foreign banks—Bank of Brussels Lambert, Dresdner Bank A.G., Kredietbank N.V., National Westminster Bank Plc and Rabo Merchant Bank N.V.—“invested $200 million in return for a priority return of interest-like payments of 6.947% per year. In theory, the foreign banks had minimal participation (1%) in Chemtech I’s residual profits. But Dow was able to control the extent of the foreign banks’ profit participation through a contractual provision that enabled it to remove profitable patents from Chemtech I’s patent portfolio,” according to the Fifth Circuit’s May 2016 opinion.
The Supreme Court’s Jan. 9 rejection also leaves in place the Fifth Circuit’s ruling that Dow couldn’t claim that it had substantial legal authority for the earlier years of the transaction, because the case cited by Dow didn’t involve the contribution-leaseback transactions. Dow could have avoided the penalty if it could show that the court in the case it relied on ruled favorably for a taxpayer that engaged in a similar transaction.
The Internal Revenue Service declined to comment. Dow’s legal counsel didn’t respond to a request for comment.
To contact the reporter on this story: Erin McManus in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Meg Shreve at email@example.com
Additional information is available in Bloomberg BNA's Supreme Court Docket Watch: 2016-17 Term Tax Law Cases.
Copyright © 2017 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)